Pentokey Organy (India) Limited (BOM:524210)
32.79
-0.19 (-0.58%)
At close: Aug 24, 2026
Pentokey Organy (India) Revenue
Pentokey Organy (India) had revenue of -29.72M INR in the twelve months ending June 30, 2026. In the fiscal year ending March 31, 2026, Pentokey Organy (India) had annual revenue of 20.90M with 152.98% growth.
Revenue (ttm)
-29.72M
Revenue Growth
+152.98%
P/S Ratio
-6.91
Revenue / Employee
-9.91M
Employees
3
Market Cap
205.43M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 20.90M | 12.64M | 152.98% |
| Mar 31, 2025 | 8.26M | -35.70M | -81.21% |
| Mar 31, 2024 | 43.96M | 308.00K | 0.71% |
| Mar 31, 2023 | 43.66M | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Dipna Pharmachem | 1.29B |
| Chandra Bhagat Pharma | 1.17B |
| Medico Intercontinental | 845.82M |
| Medistep Healthcare | 708.31M |
| Zenlabs Ethica | 496.22M |
| Constronics Infra | 454.43M |
| Goldline Pharmaceutical | 311.98M |